beyond spring pharma stock

Shares of BeyondSpring BYSI -237 a clinical-stage biotech company have been surging this week in response to a lucrative new partnership with Jiangsu Hengrui. EDT on Friday following the drugmakers.

Stock Overview Beyondspring

Companies this small are.

. Discover our most recent and upcoming events as well as download informative presentationsall right here. They recently received or are about to receive 30mn. BYSI now has a market cap of 132mn a cash reserve of 93mn a small debt of 45mn and a large short interest of 23.

Ramon Mohanlal MD PhD. Lan Huang Beyond Springs co-founder chairman and chief executive officer. Processa Pharmaceuticals has a consensus price target of.

BeyondSpring is a noticeably small company with a market capitalisation of US392m. The stock recently traded at 2711 compared with its Tuesday close at 963. BeyondSpring Inc a clinical stage biopharmaceutical company together with its subsidiaries focuses on the development and commercialization of immuno-oncology cancer.

Find real-time BYSI - Beyondspring Inc stock quotes company profile news and forecasts from CNN Business. It had slid 27 in the six months through Tuesday. Mohanlal has more than 20 years of global experience in strategic.

Headquartered in New York City we are committed to raising the standard of care for cancer patients with first-in-class treatments that improve lives and clinical outcomes for. In China we own a 5797 interest in our. BeyondSpring now will take its case to the.

- Company to host call today April 14 2022 at 800 am ET -. All quotes are in local exchange time. Events presentations.

1 day agoBeyondSpring presently has a consensus price target of 3000 suggesting a potential upside of 230000. Learn More About Our Differentiated RD Strategy. New target price is 462 above last closing price of US243.

Shares of BeyondSpring NASDAQ. Learn More About Our Differentiated RD Strategy. The service offers end-to-end research on both investing and trading ideas everyday and includes a 150-stock watchlist and two 40-stock model portfolios that are.

Is a global biopharmaceutical company that is focused on developing immuno-oncology cancer therapies. Shares of BeyondSpring BYSI 360 -- a clinical-stage biopharmaceutical company -- are down by 181 as of 1126 am. Find the latest BeyondSpring Inc.

Joining us on todays call is Dr. Up from US1175 the current price target is an average from 4 analysts. Ad Horizon Is A Leading High-Growth Biopharma Company.

1 We own global rights to plinabulin in all countries except China. BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update. Intraday data delayed at least 15 minutes or per exchange.

Price target increased to US1367. BYSI stock quote history news and other vital information to help you with your stock trading and investing. Clinical stage biopharma companies BeyondSpring BYSI and CTI BioPharma CTIC have gained 49 and 45 in the pre-market respectively on below-average volume.

Stock quotes reflect trades reported through Nasdaq only. The Closing Price Days High Days Low and Days Volume have been adjusted to account for any stock splits andor dividends. BYSI Q4 2021 Earnings Call Transcript.

Most companies this size are not always actively traded. Shares of BeyondSpring BYSI 372 soared on Wednesday after the pharmaceutical company released promising clinical trial results for its investigational lung. Real-time last sale data for US.

BYSI stock are taking off on Wednesday following an important update regarding the firms lung cancer treatment. According to the issued ratings of 6 analysts in the last year the consensus rating for BeyondSpring stock is Hold based on the current 1 sell rating 3 hold ratings and 2 buy. Ad Horizon Is A Leading High-Growth Biopharma Company.

Mohanlal has served on the Board of Directors of BeyondSpring Inc. Beyond Springs co-founder chairman and. BeyondSpring is a global clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from.

Beyondspring News Today Why Did Beyondspring Go Down Today Nasdaq Bysi